Cansino Biologics Stock Return On Asset
| 688185 Stock | 61.23 0.13 0.21% |
Cansino Biologics fundamentals help investors to digest information that contributes to Cansino Biologics' financial success or failures. It also enables traders to predict the movement of Cansino Stock. The fundamental analysis module provides a way to measure Cansino Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cansino Biologics stock.
Cansino | Return On Asset |
Cansino Biologics Company Return On Asset Analysis
Cansino Biologics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Cansino Biologics Return On Asset | -0.0792 |
Most of Cansino Biologics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cansino Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Cansino Total Assets
Total Assets |
|
Based on the latest financial disclosure, Cansino Biologics has a Return On Asset of -0.0792. This is 99.09% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all China stocks is 43.43% lower than that of the firm.
Cansino Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cansino Biologics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cansino Biologics could also be used in its relative valuation, which is a method of valuing Cansino Biologics by comparing valuation metrics of similar companies.Cansino Biologics is currently under evaluation in return on asset category among its peers.
Cansino Fundamentals
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0792 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 9.74 B | ||||
| Shares Outstanding | 114.78 M | ||||
| Shares Owned By Insiders | 62.90 % | ||||
| Shares Owned By Institutions | 3.68 % | ||||
| Price To Book | 3.11 X | ||||
| Price To Sales | 14.29 X | ||||
| Revenue | 345.18 M | ||||
| Gross Profit | (183.71 M) | ||||
| EBITDA | (829.73 M) | ||||
| Net Income | (1.45 B) | ||||
| Total Debt | 1.39 B | ||||
| Book Value Per Share | 20.58 X | ||||
| Cash Flow From Operations | (916.25 M) | ||||
| Earnings Per Share | (3.51) X | ||||
| Target Price | 61.34 | ||||
| Number Of Employees | 1.49 K | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 10.7 B | ||||
| Total Asset | 9.32 B | ||||
| Retained Earnings | (1.56 B) | ||||
| Working Capital | 2.59 B | ||||
| Net Asset | 9.32 B |
About Cansino Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cansino Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cansino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cansino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cansino Stock
Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.